Lim, Huezin H. http://orcid.org/0000-0003-2888-6088
Hopkins, Ashley M.
Rowland, Andrew
Yuen, Hoi Y.
Karapetis, Christos S.
Sorich, Michael J.
Funding for this research was provided by:
Cancer Council South Australia (1159924, 1127220)
Article History
First Online: 1 November 2019
Compliance with Ethical Standards
:
: This study was undertaken with the financial support of Cancer Council South Australia’s Beat Cancer Project on behalf of its donors and the state government through the Department of Health (Grant ID: 1159924 and 1127220). AMH is a researcher funded by a Postdoctoral Fellowship from the National Breast Cancer Foundation, Australia (PF-17-007).
: Michael J. Sorich and Andrew Rowland have received investigator-initiated project grants from Pfizer, outside the scope of the submitted work. Christos S. Karapetis has undertaken advisory board roles with AstraZeneca, Merck Sharp & Dohme, Bristol-Myers Squibb, and Roche, outside the submitted work. Huezin H. Lim, Ashley Hopkins, and Hoi Y. Yuen have no conflicts of interest that might be relevant to the contents of this manuscript.
: All authors were involved in literature search, design, analysis, interpretation and manuscript preparation for this project.